Table 3.
Numbers of recently treated patients given each therapeutic option during ERT shortages according to date
| ERT/SRT | 2009/06/01 | 2009/06/30 | 2009/08/30 | 2010/04/01 | 2010/12/31 |
|---|---|---|---|---|---|
| Imiglucerase* |
|
|
|
|
|
| >15 years |
176 |
153 |
71 |
105 |
98 |
| ≤15 years |
32 |
32 |
25 |
27 |
28 |
| Velaglucerase |
– |
– |
– |
– |
45 |
| Taliglucerase |
– |
– |
– |
– |
24 |
| Miglustat |
11 |
14 |
20 |
22 |
21 |
| Without treatment |
28 |
48 |
131 |
93 |
31 |
| Total | 247 | 247 | 247 | 247 | 247 |
Note that recent refers to 2009–2010, i.e., the last 2 years.
*Only imiglucerase was prescribed to adults (>15 years) or children (≤15 years).